Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: WE PHARMA, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2023-03-23 to 2023-09-30
Current total value of award: $240000
Description: PHARMACEUTICAL PRODUCTS FOR FDA/OPQ DOMESTIC MANUFACTURING AND REGULATORY PURPOSES.